bpc-157 evidence review human clinical trials safety regulatory status BPC-157 What is BPC-157? | Everything
Description
PMID 13348621
Body size and build
Research protocols measuring acute NNMT inhibition kinetics benefit from IM's faster Tmax, allowing tighter correlation between dosing time and metabolic measurements
In preclinical studies, BPC-157 demonstrated an exceptionally wide therapeutic window with no observed toxicity even at high doses. Sikiric et al., Current Pharmaceutical Design Long-Term Safety As of now, long-term human safety data is lacking
Copper peptides are naturally produced by our bodies, but as we age, the amount that we have is significantly reduced
